Clinical Trial Update: A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial comparing amisulpride alone to a low-dose amisulpride plus sulpiride regimen in schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Amisulpride (amisulpride)
• Sulpiride (sulpiride)

Snippet

Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED